Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Antonuzzo

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 29, 2022
Current status and future perspectives in HER2 positive advanced gastric cancerG Roviello, M Catalano, L F Iannone, et al.
Case Reports in Medicine|September 3, 2009
Primary cardiac angiosarcoma: a fatal diseaseL Antonuzzo, V Rotella, F Mazzoni, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 6, 2026
Navigating Disappearing Liver Metastases in Colorectal Cancer: A Review of Surgical and Non-Surgical ApproachesI Valle, C Conticello, D Ravizza, et al.
Cancer Treatment Reviews|May 24, 2017
Critical focus on mechanisms of resistance and toxicity of m-TOR inhibitors in pancreatic neuroendocrine tumorsL Antonuzzo, M Del Re, V Barucca, et al.
Journal of Biophotonics|July 17, 2024
Delineation of gastrointestinal tumors biopsies using a fluorescence lifetime imaging optical fiber probeD Suraci, E Baria, L Tirloni, et al.
ESMO Open|February 4, 2021
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor BoardsR Danesi, S Fogli, S Indraccolo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2015
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trialG Masi, L Salvatore, L Boni, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinomaL Antonuzzo, M Maruzzo, U De Giorgi, et al.
ESMO Real World Data and Digital Oncology|April 3, 2026
Predicting efficacy in patients with locally advanced/metastatic urothelial carcinoma (mUC) treated with immunotherapy using explainable machine learning approaches: the SamUR-AI trial on behalf of the Meet-URO groupA Rametta, S Ferri, M Maruzzo, et al.
ESMO Open|January 28, 2025
Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trialF Piscaglia, G Masi, E Martinelli, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 29, 2022
Current status and future perspectives in HER2 positive advanced gastric cancerG Roviello, M Catalano, L F Iannone, et al.
Case Reports in Medicine|September 3, 2009
Primary cardiac angiosarcoma: a fatal diseaseL Antonuzzo, V Rotella, F Mazzoni, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 6, 2026
Navigating Disappearing Liver Metastases in Colorectal Cancer: A Review of Surgical and Non-Surgical ApproachesI Valle, C Conticello, D Ravizza, et al.
Cancer Treatment Reviews|May 24, 2017
Critical focus on mechanisms of resistance and toxicity of m-TOR inhibitors in pancreatic neuroendocrine tumorsL Antonuzzo, M Del Re, V Barucca, et al.
Journal of Biophotonics|July 17, 2024
Delineation of gastrointestinal tumors biopsies using a fluorescence lifetime imaging optical fiber probeD Suraci, E Baria, L Tirloni, et al.
ESMO Open|February 4, 2021
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor BoardsR Danesi, S Fogli, S Indraccolo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2015
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trialG Masi, L Salvatore, L Boni, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinomaL Antonuzzo, M Maruzzo, U De Giorgi, et al.
ESMO Real World Data and Digital Oncology|April 3, 2026
Predicting efficacy in patients with locally advanced/metastatic urothelial carcinoma (mUC) treated with immunotherapy using explainable machine learning approaches: the SamUR-AI trial on behalf of the Meet-URO groupA Rametta, S Ferri, M Maruzzo, et al.
ESMO Open|January 28, 2025
Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trialF Piscaglia, G Masi, E Martinelli, et al.
Pageof 3